Conclusions
Key EGM selection reduced the EGM burden by 55%, with no
delay-to-diagnosis in 99% of patients who exhibited a true arrhythmia.
Implementing these rules by enabling a feature on the manufacturer’s
patient care network may accelerate clinical workflow without
compromising diagnostic timelines, ultimately streamlining ICM patient
management.